Molecular alchemy of the tumor suppressor protein p53: Metals and cell growth control

Journal of Trace Elements in Experimental Medicine

Volumn 12, Issue 4, 1999, Pages 337-346

  Méplan, Catherine ^a   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cadmium; Cancer; Cell cycle; Oxidation reduction

Indexed keywords

CADMIUM; METAL; METAL CHELATE; PROTEIN P53; TRANSCRIPTION FACTOR; ZINC;

CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; DNA BINDING; DNA REPAIR; GENE MUTATION; GROWTH REGULATION; PRIORITY JOURNAL; STRESS;

EID: 1642602482     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-670X(1999)12:4<337::AID-JTRA7>3.0.CO;2-J     Document Type: Conference Paper

References (41)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
2. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997;91:325-334.
3. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PW. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 1998;394:700-704.
4. Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 1999;77:81-137.
5. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998;273:1-274.
6. Meek DW. Multisite phosphorylation and the integration of stress signals at p53. Cell Signal 1998; 10:159-166.
7. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387: 296-299.
8. Kubbutat MH, Jones SN, Vousden, KH. Regulation of p53 stability by Mdm2. Nature 1997;387: 299-303.
9. Hupp TR, Meek DW, Midgley CA, Lane DP. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res 1993;21:3167-174.
10. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996;10:1054-1072.
11. Hainaut P, Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993;53:4469-4473.
12. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995;15:3892-3903.
13. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997;11:558-570.
14. Milner J. Flexibility: the key to p53 function? Trends Biochem Sci 20:49-51.
15. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997;389:300-305.
16. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 1998;17:4668-4679.
17. Lane DP. Cancer: p53, guardian of the genome. Nature 1992;358:15-16.
18. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC, Montesano R. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 1998;26:205-213.
19. Arrowsmith CH, Morin P. New insights into p53 function from structural studies. Oncogene 1996; 12:1379-1385.
20. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nature Genet 1992;1:45-49.
21. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994;265:346-355.
22. O'Halloran TV. Transition metals in control of gene expression. Science 1993;261:715-725.
23. Hainaut P, Milner J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res 1993;53:1739-1742.
24. Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 1993;7:2556-2564.
25. Delphin C, Cahen, P, Lawrence JJ, Baudier J. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur J Biochem 1994;223:683-692.
26. Hainaut P, Rolley N, Davies M, Milner J. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 1995;10:27-32.
27. Verhaegh GW, Parat MO, Richard M.J, Hainaut P. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Mol Carcinog 1998;21:205-214.
28. Hainaut P, Milner J. Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J 1992; 11:3513-3520.
29. Verhaegh GW, Richard MJ, Hainaut, P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol 1997;17:5699-5706.
30. Wu HH, Momand J. Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J Biol Chem 1998;273:18898-18905.
31. International Agency for Cancer Research Beryllium, Cadmium, Mercury and exposures in the glass manufacturing industry. IARC Monographs on the Evaluation of Carcinogenic Risks 1998;58: pp. 119-237.
32. Meplan C, Mann K, Hainaut P. Cadmium induces conformational modifications of Wild-type p53 and suppresses p53 response to DNA damage in intact cells. J Biol Chem 1999 (in press).
33. Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 1997;57:3365-3369.
34. Berg JM, Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996;271:1081-1085.
35. Glusker JP. Structural aspects of metal liganding to functional groups in proteins. Adv Protein Chem 1991;42:1-76.
36. Kagi JH. Overview of metallothionein. Methods Enzymol 1991;205:613-626.
37. Nagel WW, Vallee, BL. Cell cycle regulation of metallothionein in human colonie cancer cells. Proc Natl Acad Sci USA 1995;92:579-583.
38. Dally H, Hartwig A. Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis 1997;18:1021-1026.
39. Wu J, Forbes JR, Chen HS, Cox, DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet 1994;7:541-545.
40. Fong LY, Li JX, Farber JL, Magee PN. Cell proliferation and esophageal carcinogenesis in the zinc-deficient rat. Carcinogenesis 1996;17:1841-1848.
41. Muñoz N, Wahrendorf J , Bang LJ, Crespi M, Thurnham DI, Day NE, Ji ZH, Grassi A, Yan LW, Lin LG. No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus: randomised double-blind intervention study in high-risk population of China. Lancet 1985;2:111-114.